Finance

Lists
CTX:WSE
Captor Therapeutics SA
PLN 50.80
+1.40%
(+0.70) 1D
Nov 4, 5:00:00 PM GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
PLN 50.00
High
PLN 51.00
Low
PLN 50.00
Mkt. cap
323.21M
Avg. vol.
7.38K
Volume
4.48K
52-wk high
PLN 89.20
52-wk low
PLN 44.10
EPS
-PLN 7.77
Shares outstanding
6.36M
No. of employees
82
Open
PLN 50.00
High
PLN 51.00
Low
PLN 50.00
Mkt. cap
323.21M
Avg. vol.
7.38K
Volume
4.48K
52-wk high
PLN 89.20
52-wk low
PLN 44.10
EPS
-PLN 7.77
Shares outstanding
6.36M
No. of employees
82
News stories
From web sources and news partners
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
SectorBiotechnology
Industry-
Websitecaptortherapeutics.com
Last report
Sep 15, 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
1.63M / 1.50M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
44.00K
328.00K
1.63M
Cost of goods sold
-2.02M
-
-
173.00K
Cost of revenue
-2.02M
-
-
173.00K
Research and development expenses
14.74M
9.82M
10.56M
13.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.37M
2.53M
1.92M
2.25M
Operating expense
13.83M
10.40M
11.59M
14.39M
Total operating expenses
11.81M
10.40M
11.59M
14.56M
Operating income
-11.81M
-10.36M
-11.26M
-12.93M
Other non operating income
1.00K
-8.00K
-
-
EBT including unusual items
-11.48M
-10.05M
-11.35M
-11.39M
EBT excluding unusual items
-11.48M
-10.12M
-11.35M
-11.39M
Income tax expense
-
-
27.00K
-
Effective tax rate
-
-
-0.24%
-
Other operating expenses
-2.27M
-1.94M
-893.00K
-1.64M
Net income
-11.48M
-10.05M
-11.38M
-11.39M
Net profit margin
-
-22,831.82%
-3,467.99%
-696.88%
Earnings per share
-
-
-
-
Interest and investment income
391.00K
303.00K
39.00K
1.63M
Interest expense
-61.00K
-75.00K
-67.00K
-57.00K
Net interest expenses
330.00K
228.00K
-28.00K
1.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.81M
-9.53M
-10.36M
-12.04M
Gain or loss from assets sale
-682.00K
-
-
-128.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps